Systemic Administration of Insulin-Like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) Increases Bone Formation Parameters in Mice by Increasing IGF Bioavailability via an IGFBP-4 Protease-Dependent Mechanism
Open Access
- 1 June 2001
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 142 (6), 2641-2648
- https://doi.org/10.1210/en.142.6.2641